<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01983605</url>
  </required_header>
  <id_info>
    <org_study_id>RS-001 V3.0_120709</org_study_id>
    <nct_id>NCT01983605</nct_id>
  </id_info>
  <brief_title>Left Atrial Appendage Exclusion Study</brief_title>
  <acronym>PLACE II</acronym>
  <official_title>Left Atrial Appendage Exclusion Study II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SentreHEART, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SentreHEART, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the safety and effectiveness of the LARIAT Suture Delivery device in excluding the
      left atrial appendage in 100 patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the safety and effectiveness of the SentreHEART
      suture delivery system for the exclusion of the left atrial appendage in up to 100 treated
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of device related serious adverse events</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of patients with complete exclusion of the LAA measured with TEE</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Atrial Appendage</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LAA exclusion with the LARIAT Suture Delivery Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LARIAT Suture Delivery Device</intervention_name>
    <description>LAA exclusion procedure</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is greater than or equal to 18 years of age

          2. Subject has atrial fibrillation (paroxysmal or persistent)

          3. Subject is poor candidate for Warfarin (contraindicated, labile INR, non-compliant)

          4. Subject is willing and able to provide written informed consent

          5. Subject has a life expectancy of at least 1 year

          6. Subject is willing and able to return for scheduled follow up visits

        Exclusion Criteria:

          1. Previous cardiac surgery

          2. Thrombus in the left atrial appendage or left atrium

          3. NYHA Class IV heart failure symptoms

          4. Need for emergent cardiac surgery (i.e. cardiogenic shock)

          5. LAA is not appropriate for exclusion based upon intraoperative evaluations

          6. Current diagnosis of active systemic infection

          7. Renal failure requiring dialysis or hepatic failure

          8. A known drug and/or alcohol addiction

          9. Mental impairment or other conditions, which may not allow subject to understand the
             nature, significance and scope of the study

         10. Pregnancy or desire to get pregnant within 12 months of the study treatment

         11. Preoperative need for an intra-aortic balloon pump or intravenous inotropes

         12. Patients who have been treated with thoracic radiation

         13. Patients in current chemotherapy

         14. Patients on long-term treatment with steroids not including intermittent use of
             inhaled steroids for respiratory diseases.

         15. Patients with known connective tissue disorders, i.e. Lupus

         16. Previous history of pericarditis

         17. Presence of a PFO/ASD or valve implant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerzy Sadowski, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jagiellonian University (John Paul II) Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jagiellonian University (John Paul II) Hospital</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013 Jul 9;62(2):108-118. doi: 10.1016/j.jacc.2012.06.046. Epub 2012 Oct 10.</citation>
    <PMID>23062528</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>November 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2013</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

